Plexera Bioscience and MitoSciences Inc. Announce Collaboration on Mitochondrial Array

Plexera Bioscience LLC, a wholly owned subsidiary of Lumera Corporation (NASDAQ:LMRA), and MitoSciences Inc., developers of antibodies and assays for understanding mitochondrial function, announced today that they have entered into an agreement that outlines a commercial path for an antibody array product which is enabled with Plexera’s ProteomicProcessor(TM) and MitoSciences’ proprietary antibodies.

Source: Lumera/Business Wire